Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Current Hypertension Reports|November 22, 2001
Evidence for cardioprotective, renoprotective, and vasculoprotective effects of vasopeptidase inhibitors in diseaseE Kubota, R G Dean, R A Hubner, et al.
Clinical Endocrinology|November 27, 2015
Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumoursP J Monaghan, A Lamarca, J W Valle, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
The influence of adjuvant chemotherapy on outcome after relapse for patients with breast cancerS J Houston, M A Richards, A E Bentley, et al.
British Journal of Cancer|November 1, 2007
Thymidylate synthase polymorphisms, folate and B-vitamin intake, and risk of colorectal adenomaR A Hubner, J-F Liu, G S Sellick, et al.
British Journal of Cancer|March 31, 1999
Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancerS J Houston, T A Plunkett, D M Barnes, et al.
The British Journal of Surgery|December 1, 1994
Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinomaM S Highley, F X Parnis, G A Trotter, et al.
Surgical Oncology|August 28, 2016
Prognostic factors for disease relapse in patients with neuroendocrine tumours who underwent curative surgeryA E Slagter, D Ryder, B Chakrabarty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancerM Dowsett, C Pfister, S R Johnston, et al.
Medical Oncology (Northwood, London, England)|September 8, 2019
Outcomes in patients ≥ 80 years with a diagnosis of a hepatopancreaticobiliary (HPB) malignancyA R Lewis, C Cipriano, X Wang, et al.
British Journal of Cancer|February 1, 1996
Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancerH R Bonnefoi, I E Smith, M Dowsett, et al.
Pageof 3